Christian Morrison, DPM
Primary Podiatric Medicine · Murphy, TXNPI 1487159570
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,398 of the $5,994 with a category attached, or 73.4%. 13 manufacturers reported payments, led by Stryker at 59.5% of the total. Reporting peaked in 2023 at $3,108 and has fallen 74.7% since, to $785 in 2025.
Across 106 payments — averaging $56.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Smith+Nephew$1K
- Abbott$213
- Paragon 28, Inc.$193
- Averitas Pharma Inc.$165
- Biotissue Holdings Inc.$163
- plus $578 from 7 others
What the payments were for
- Travel & lodging$1,59727%
- Food & beverage$4,39873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 35 | $3,565 |
| Smith+Nephew | 47 | $1,116 |
| Abbott | 2 | $213 |
| Paragon 28, Inc. | 1 | $193 |
| Averitas Pharma Inc. | 2 | $165 |
| Biotissue Holdings Inc. | 2 | $163 |
| Paratek Pharmaceuticals, Inc. | 8 | $138 |
| Polynovo North America LLC | 2 | $129 |
| Cardiovascular Systems Inc. | 2 | $95 |
| Integra Lifesciences Corporation | 2 | $91 |
| Medtronic | 1 | $89 |
| Axogen | 1 | $24 |
| Pylant Medical | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$2,594
- AXSOS$1,524
- VARIAX$1,524
- HOFFMANN$1,524
- GAMMA$1,524
- GRAFIX PL$390
- STRAVIX PL$263
- Product Portfolio$193
- ENSITE$189
- INFINITY ADAPTIS$175
- NEOX$153
- CLARIX$153
- Qutenza$140
- 1788$114
- Actishield$100
How this compares
$5,994 in reported general payments places this provider in the 80th percentile of 36 primary podiatric medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 18 | $461 |
| Duloxetine Hcl | 45 | $443 |
| Doxycycline Monohydrate | 20 | $259 |
| Methylprednisolone | 22 | $165 |
| Meloxicam | 50 | $77 |
| Cephalexin | 11 | $53 |
| Gabapentin | 15 | $51 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Murphy
- Kenneth WilliamsSan Antonio$26K
- Tomas TrevinoEl Campo$17K
- Irene ArroyoDallas$11K
- Fernando FernandezThe Woodlands$7K
- Susie Sant'annaFredericksburg$7K
- Silas SalanoArlington$6K
- Barton GarciaShenandoah$5K
- Eric HigginsDumas$3K
- Maureen CaldwellVictoria$3K
- Andrew YoungVictoria$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.